GANX Market Cap & Key Metrics
Gain Therapeutics, Inc.
$1.33
+$0.01(+0.76%)
24
Overall
40
Value
10
Tech
23
Quality
Market Cap
$57.61M
Volume
501.27K
52W Range
$1.53 - $4.34
Target Price
$7.20
GANX market cap is $57.61M. This page lists Gain Therapeutics, Inc.'s P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
GANX Key Metrics
- Market cap
- $57.61M
- EPS estimate, current year
- $-0.50
- EPS growth, 3-year
- +25.58%
- Value score
- 40
- Quality score
- 23
- Technical score
- 10
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | - | - | $55.2K | $140.1K | $165.0K |
| EBITDA | -$19.45M | -$20.15M | -$22.10M | -$17.71M | -$13.88M |
| EPS | $-0.61 | $-0.89 | $-1.71 | $-1.48 | $-1.37 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GANX | $1.33 | +0.8% | 501.27K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |